Just an excerpt from an article I read. The link to the original is available at the end.
Alba Bioscience receives funding to secure 16 R&D jobs
17 September 2008
Sarah Cross
Edinburgh-based Alba Bioscience announced a major investment today (Tuesday 16 September 2008) to create and secure 16 high value research and development jobs and support the development of novel technologies in life science diagnostics.
This investment will include a £1.8million R&D grant from Scottish Enterprise, which was announced by Enterprise Minister Jim Mather at a visit to Alba Bioscience.Scotland has an international reputation for quality research and development – especially in the field of life sciences
He said: “Scotland has an international reputation for quality research and development – especially in the field of life sciences. This excellence is demonstrated by the work of Alba Bioscience, which has built a highly-skilled Edinburgh-based workforce. The R&D grant will enable the company to go from strength to strength and, in turn, help this Government in our drive to increase sustainable economic growth.”
John Allan, CEO of Alba Bioscience highlighted that: “Some of the key factors of this award will be the creation and safeguarding of new research and development jobs, which will enhance our current scientific skill base and assist our growth. This strengthens the company’s contribution to the economy locally and in the development of Scotland’s expertise in the life science arena.”
Alba Bioscience is one of the success stories in the life sciences industry in Scotland. The progressive company is a world leader in the manufacture of vital diagnostic reagents. It is now one of the largest manufacturers of monoclonal blood grouping products in the world, with over 70 per cent of their sales coming from overseas. Its wide-ranging product portfolio includes contract manufacturing services in cryo preservation, freeze drying as well as antibody production.
The company is expanding rapidly following its privatisation from the NHS last year and a major milestone was achieved when FDA (Food and Drug Administration) clearance was received last year to sell some of its products into the highly-lucrative U.S. market.
Read the full article here.
careerxpert001
